Literature DB >> 15646662

Second transplantation from HLA 2-loci-mismatched mother for graft failure due to hemophagocytic syndrome after cord blood transplantation.

Takayuki Tanaka1, Hiroshi Matsubara, Souichi Adachi, Hsi Chang, Hisanori Fujino, Yuri Higashi, Takahiro Yasumi, Michihiro Kobayashi, Ken-ichiro Watanabe, Munehisa Takahashi, Yoshiro Kobayashi, Etsuko Maruya, Hiroh Saji, Tatsutoshi Nakahata.   

Abstract

A 7-year-old girl with acute myelogenous leukemia with multilineage dysplasia received unrelated cord blood transplantation but developed hemophagocytic syndrome (HPS) after sepsis with methicillin-resistant coagulase-negative staphylococci before engraftment. Bone marrow aspiration on day 20 revealed a markedly increased number of activated macrophages showing hemophagocytosis. The presence of donor-type chimera in the bone marrow was confirmed at that time. We therefore quickly started immunosuppressive and antibacterial treatment. Although her condition gradually improved, the patient suffered graft failure due to HPS. She received peripheral blood stem cell transplantation from her HLA 2-loci-mismatched mother on day 54 and continued in complete remission 12 months after the second transplantation. The results in this case suggested that because of fetomaternal microchimerism it may be useful to select an HLA-haploidentical mother as a backup donor for stem cell transplantation.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15646662     DOI： 10.1532/ijh97.04063

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  8 in total

Review 1.  Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation.

Authors:  K Fukuno; H Tsurumi; T Yamada; M Oyama; H Moriwaki
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Feto-maternal microchimaerism does not indicate the existence of feto-maternal immunological tolerance in human leucocyte antigen haploidentical haematopoietic stem cell transplantation from mother to offspring.

Authors:  Naoya Ochiai; Tohru Inaba; Etsuko Maruya; Hiroh Saji; Masao Nakagawa; Chihiro Shimazaki
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

3.  Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism.

Authors:  Chihiro Shimazaki; Naoya Ochiai; Ryo Uchida; Akira Okano; Shin-ichi Fuchida; Eishi Ashihara; Tohru Inaba; Naohisa Fujita; Etsuko Maruya; Masao Nakagawa
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases.

Authors:  N Takahashi; A Chubachi; M Kume; Y Hatano; A Komatsuda; Y Kawabata; N Yanagiya; Y Ichikawa; A B Miura; I Miura
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

5.  Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Y Abe; I Choi; K Hara; T Matsushima; J Nishimura; S Inaba; H Nawata; K Muta
Journal:  Bone Marrow Transplant       Date:  2002-05       Impact factor: 5.483

6.  Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation.

Authors:  J Ishikawa; T Maeda; T Miyazaki; N Manabe; S Honda; T Nishiura; Y Tomiyama; Y Matsuzawa
Journal:  Int J Hematol       Date:  2000-08       Impact factor: 2.490

Review 7.  Hemophagocytic syndrome (HPS) in children and adults.

Authors:  H Tsuda
Journal:  Int J Hematol       Date:  1997-04       Impact factor: 2.490

8.  Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning.

Authors:  K Umeda; S Adachi; H Ishihara; Y Higashi; M Shiota; K-I Watanabe; M Hishizawa; T Ichinohe; T Kitoh; E Maruya; H Saji; T Uchiyama; T Nakahata
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483
  8 in total
  8 in total

1.  Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.

Authors:  Masahiko Sumi; Ikuo Shimizu; Keijiro Sato; Toshimitsu Ueki; Daigo Akahane; Mayumi Ueno; Naoaki Ichikawa; Shinji Nakao; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2010-11-05       Impact factor: 2.490

2.  Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

Authors:  N Kawashima; S Terakura; S Nishiwaki; D Koyama; Y Ozawa; M Ito; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

3.  Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.

Authors:  Sarita Rani Jaiswal; Aditi Chakrabarti; Sumita Chatterjee; Sneh Bhargava; Kunal Ray; Suparno Chakrabarti
Journal:  Int J Hematol       Date:  2015-11-30       Impact factor: 2.490

4.  Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents.

Authors:  Takao Yoshihara; Keiko Okada; Michihiro Kobayashi; Atsushi Kikuta; Koji Kato; Naoto Adachi; Akira Kikuchi; Hiroyuki Ishida; Yasuzou Hirota; Hiroshi Kuroda; Yoshihisa Nagatoshi; Takeshi Inukai; Kazutoshi Koike; Hisato Kigasawa; Hiroshi Yagasaki; Kiriko Tokuda; Tomoko Kishimoto; Takahide Nakano; Naoto Fujita; Hiroaki Goto; Yozo Nakazawa; Hirokazu Kanegane; Akinobu Matsuzaki; Yuko Osugi; Daiichiro Hasegawa; Nobuhiko Uoshima; Kazuhiro Nakamura; Masahiro Tsuchida; Ryuhei Tanaka; Arata Watanabe; Hiromasa Yabe
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

5.  Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.

Authors:  Naoko Satoh; Shoko Takenouchi; Shigeo Hashimoto; Masahiro Fujiwara; Tadashi Koike
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

6.  Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.

Authors:  R Kobayashi; J Tanaka; S Hashino; S Ota; Y Torimoto; Y Kakinoki; S Yamamoto; M Kurosawa; N Hatakeyama; Y Haseyama; H Sakai; K Sato; T Fukuhara
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483

7.  Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study.

Authors:  Abderrahman Abdelkefi; Wassim Ben Jamil; Lamia Torjman; Saloua Ladeb; Habib Ksouri; Amel Lakhal; Assia Ben Hassen; Abdeladhim Ben Abdeladhim; Tarek Ben Othman
Journal:  Int J Hematol       Date:  2009-02-28       Impact factor: 2.490

8.  Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.

Authors:  J Kanda; M E Horwitz; G D Long; C Gasparetto; K M Sullivan; J P Chute; A Morris; T Hennig; Z Li; N J Chao; D A Rizzieri
Journal:  Bone Marrow Transplant       Date:  2011-08-01       Impact factor: 5.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.